Marco Matucci‐Cerinic
Marco Matucci‐Cerinic publishes mostly in Pathology and Forensic Medicine, Rheumatology and Pulmonary and Respiratory Medicine, on topics such as Systemic Sclerosis and Related Diseases, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis and Inflammatory Myopathies and Dermatomyositis.
- World rank
- #98,635 of 7,710,434 ranked researchers
- Rank in Italy
- #1,883 of 242,206
- Works
- 1,231
- Citations
- 53k
- Citations per work
- 42.8
What does Marco Matucci‐Cerinic research?
Marco Matucci‐Cerinic's work is mostly in Medicine (65%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences80465.3%
- Medicine80465.3%
- Everything else42734.7%
- 1Pathology and Forensic Medicine26% of their works
- 2Rheumatology12% of their works
- 3Pulmonary and Respiratory Medicine11% of their works
- 4Epidemiology6% of their works
- 5Dermatology5% of their works
- 6Surgery4% of their works
Research topics
- Systemic Sclerosis and Related Diseases
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Inflammatory Myopathies and Dermatomyositis
- Rheumatoid Arthritis Research and Therapies
- Dermatologic Treatments and Research
- Pulmonary Hypertension Research and Treatments
- Connective Tissue Growth Factor Research
- Multiple Sclerosis Research Studies
Which keywords describe Marco Matucci‐Cerinic's research?
The keywords of their largest research topics: Autoantibodies, Fibrosis, Treatment, Endothelial Dysfunction, TGF-ß Signaling, Pulmonary Involvement, Systemic Sclerosis and Interstitial Lung Disease.
- Diagnostic Criteria
- CCN Family
- Pulmonary Hypertension
- Hypertrophic Scarring
- Inflammation
- Dermatomyositis
- TGF-ß
- Interstitial Lung Disease
- Pulmonary Involvement
- Endothelial Dysfunction
- Fibrosis
- Autoantibodies
- Treatment
- TGF-ß Signaling
- Systemic Sclerosis
- Idiopathic Pulmonary Fibrosis
- Wound Healing
- Inflammatory Myopathies
- Rheumatoid Arthritis
- Keloids
- Right Heart Assessment
- Connective Tissue Growth Factor
- Multiple Sclerosis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Autoantibodies1,0683 topics
- Fibrosis1,0313 topics
- Treatment9352 topics
- Endothelial Dysfunction8392 topics
- TGF-ß Signaling8362 topics
- Pulmonary Involvement7571 topic
- Systemic Sclerosis7571 topic
- Interstitial Lung Disease3732 topics
- Idiopathic Pulmonary Fibrosis1951 topic
- TGF-ß1951 topic
- Wound Healing1862 topics
- Dermatomyositis1781 topic
- Inflammatory Myopathies1781 topic
- Inflammation1331 topic
- Rheumatoid Arthritis1331 topic
- Hypertrophic Scarring1071 topic
- Keloids1071 topic
- Pulmonary Hypertension821 topic
- Right Heart Assessment821 topic
- CCN Family791 topic
- Connective Tissue Growth Factor791 topic
- Diagnostic Criteria711 topic
- Multiple Sclerosis711 topic
Where does Marco Matucci‐Cerinic work?
Marco Matucci‐Cerinic's main affiliation in the publication record is University of Florence, Italy.
How many publications and citations does Marco Matucci‐Cerinic have?
OpenAlex counts 1,231 works and 52,667 citations for Marco Matucci‐Cerinic, an h-index of 101, ranking #98,635 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Marco Matucci‐Cerinic
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Marco Matucci‐Cerinic. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.